| Gene symbol | ROR1 | Synonyms | NTRKR1, dJ537F10.1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p31.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | receptor tyrosine kinase like orphan receptor 1 | ||||
| GTO ID | GTC3215 |
| Trial ID | NCT05588440 |
| Disease | B-Cell Malignancy |
| Altered gene | ROR1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ONCT-808 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies |
| Year | 2022 |
| Country | United States |
| Company sponsor | Oncternal Therapeutics, Inc |
| Other ID(s) | ONCT-808-101 |
| Cohort 1 | |||||||||||
|
|||||||||||